09:58 AM EST - Microbix Biosystems Inc. : Will present performance results of its Quality Assessment Products supporting Human Papillomavirus molecular-diagnostic screening-tests at the 2022 annual congress of the European Research Organization on Genital Infection and Neoplasia taking place in Düsseldorf, Germany from April 10-12. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.58.
